Biopharmaceutical proteins formed as a result of fusion proteins. Their advantages are:

- synergistic activities in one molecule; thus when the molecule binds to a cell, it does two things at once;

- the adverse effect or poor stability of one molecule may be offset by the properties of the other; and

- one molecule acts as a targeting mechanism to bring the other to the site where it is meant to act.